BioVaxys Technology Corp. delayed to file its interim financial statements for the three months ended January 31, 2024. The Company anticipates filing the Required Annual Filings and the Required Interim Filings by May 13, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.07 CAD | -12.50% |
|
-.--% | +40.00% |
1st Jan change | Capi. | |
---|---|---|
+40.00% | 1.13Cr | |
+16.49% | 12TCr | |
+21.73% | 12TCr | |
+22.18% | 2.66TCr | |
-21.81% | 1.99TCr | |
-16.89% | 1.63TCr | |
-18.81% | 1.55TCr | |
-44.74% | 1.55TCr | |
+62.72% | 1.48TCr | |
+3.09% | 1.37TCr |
- Stock Market
- Equities
- BIOV Stock
- News BioVaxys Technology Corp.
- Biovaxys Technology Corp. Delays to File Its Interim Financial Statements for the Three Months Ended January 31, 2024